Driving drug discovery: the fundamental role of academic labs.
about
PyMine: a PyMOL plugin to integrate and visualize data for drug discovery.A high content screening approach to identify molecules neuroprotective for photoreceptor cellsPrions.The path from bench to bedside: considerations before starting the journeyAn NIH intramural percubator as a model of academic-industry partnerships: from the beginning of life through the valley of deathLost but making progress--Where will new analgesic drugs come from?Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery.Mitigating risk in academic preclinical drug discovery.From free to free market: cost recovery in federally funded clinical research.Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism.EATRIS, a European initiative to boost translational biomedical research.Translational research policies: disruptions and continuities in biomedical innovation systems in Austria, Finland and Germany.Innovation in academic chemical screening: filling the gaps in chemical biologyDrug development for exceptionally rare metabolic diseases: challenging but not impossibleCollaboration versus outsourcing: the need to think outside the box.The impact of network biology in pharmacology and toxicology.Alzheimer's disease drug development: translational neuroscience strategies.EATRIS, a vision for translational research in Europe."Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.The need for academic generalists.Impact of high-throughput screening in biomedical research.Synthetic Biology and the Translational Imperative.Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.Translational Research: From Biological Discovery to Public Benefit (or Not)
P2860
Q31000616-D3EDF90A-A009-44A7-97F6-8C9304669740Q34139442-6881FADD-9C1F-4B4F-8C91-A42EB1134F31Q34413061-5AC93B4E-C717-44F4-B0FB-5A09467FF41AQ34630194-2100A39E-32F4-48ED-8FE9-C11808D43BA3Q35053988-95A13BCB-8AF8-4792-8E1A-29CA667C6777Q35058471-9EC6EF4F-872F-402E-B3D5-DA04A5C81B40Q35111663-B5CC3C57-A67A-48DC-9CA0-1186E3DB2B47Q35180535-24E575B8-A7ED-41A3-A500-248D23EB08FEQ35591567-FB6E0A11-9572-4034-A73B-6135A75F42D0Q36469733-18FD93FC-573D-4459-81CD-6978D2A02815Q36553321-C22725DD-C6CF-4FD2-BACD-8F6124BA5E30Q36695934-1DDCE2C9-7392-476C-A023-E38A91E444B0Q36884593-C25B7022-CF83-4387-9BE9-615F1DA76634Q37037229-CEF35DA2-1520-4A40-BE76-F918AD8C9249Q37350225-B76140E3-40D3-4FCD-8FBC-71317F6A468AQ37958064-FE84DE3B-0F6F-4A8C-8CFC-0E765B1F9D74Q37986776-052C59A4-7A64-4913-8217-D5E4848F580BQ38087640-925ECE82-F33C-4586-A0D3-ECB15BCF91EBQ38423394-D2E79F1A-2805-46A1-9F2B-4CEFE597FF42Q38752029-3A7F7697-6C0D-4FB2-A5F6-80E3F441D098Q41854556-8C32B987-2481-46DB-B272-3CE27BF0F9B4Q45352809-211501D2-CF32-452C-907B-2F88B7AC5650Q47236154-CE9977AC-0086-420A-A759-A67727032C92Q50948653-D7A921C6-611F-42A9-93F7-98491FFE2332Q59042590-13A1B787-2B0E-47E0-B664-3CCAB59A1487
P2860
Driving drug discovery: the fundamental role of academic labs.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Driving drug discovery: the fundamental role of academic labs.
@en
Driving drug discovery: the fundamental role of academic labs.
@nl
type
label
Driving drug discovery: the fundamental role of academic labs.
@en
Driving drug discovery: the fundamental role of academic labs.
@nl
prefLabel
Driving drug discovery: the fundamental role of academic labs.
@en
Driving drug discovery: the fundamental role of academic labs.
@nl
P2860
P1476
Driving drug discovery: the fundamental role of academic labs.
@en
P2093
B Michael Silber
P2860
P304
P356
10.1126/SCITRANSLMED.3000169
P407
P577
2010-05-01T00:00:00Z